Ready to get vaccinated?
We have appointments available as early as today.
Schedule nowThere’s a powerful story behind every headline at Ohio State Health & Discovery. As one of the largest academic health centers and health sciences campuses in the nation, we are uniquely positioned with renowned experts covering all aspects of health, wellness, science, research and education. Ohio State Health & Discovery brings this expertise together to deliver today’s most important health news and the deeper story behind the most powerful topics that affect the health of people, animals, society and the world. Like the science and discovery news you find here? You can support more innovations fueling advances across medicine, science, health and wellness by giving today.
Subscribe. The latest from Ohio State Health & Discovery delivered right to your inbox.
SubscribeEditor’s note: As what we know about COVID-19 evolves, so could the information in this story. Find our most recent COVID-19 articles here and learn the latest in COVID-19 prevention at the Centers for Disease Control and Prevention. Some photos and videos on this site were filmed prior to the COVID-19 outbreak or may not reflect current physical distancing and/or masking guidelines.
As if the breathing complications associated with COVID-19 aren’t worrisome enough, doctors are discovering another risk posed by the coronavirus: blood clots that can lead to life-threatening strokes, heart attacks and pulmonary embolism.
As COVID-19 traveled across Europe and hit hard in New York City, word began to spread of patients riddled with clots in their brain, hearts, lungs and legs — and sometimes all over. In Los Angeles, doctors had to amputate the right leg of a Broadway star because of severe clotting. Medical staff at The Ohio State University Wexner Medical Center began seeing blood clots in some of their COVID-19 patients, too.
“It’s very scary for a patient and it’s alarming for a medical center, too,” says Danielle Blais, PharmD, a specialty practice pharmacist in cardiology at the Ohio State Richard M. Ross Heart Hospital. “We called in experts from so many different disciplines to figure out how best to treat these patients, and we continue to learn more every day.”
Blood clots are a serious condition: Untreated, they can cause damage to your brain, heart and lungs. Death or long-term complications are a real concern.
While the health care community is still learning the ways COVID-19 attacks the body, it appears that a few factors are causing the increased risk of blood clots, said Matthew Exline, MD, medical director of the medical intensive care unit at the Ohio State Wexner Medical Center.
First, COVID-19 can cause severe inflammation, which can trigger your clotting system.
“When you, say, fall and skin your knee, it turns your immune system on, and one of the ways your immune system reacts to an injury is by making your clotting system more active,” Dr. Exline says. “It kind of makes sense that your body would say, 'If I see an infection, I need to be ready to clot.' But when the infection is as widespread and inflammatory as COVID-19, that tendency to clot can become dangerous.”
And when you’re sick with COVID-19 or following stay-at-home or quarantine orders, you probably aren’t moving much.
“If you’re immobile, you have an increased risk factor for blood clots,” Dr. Exline says.
Paired together, inflammation and immobility create a near perfect environment for blood clots in your legs and lungs, he says. Patients with severe cases of COVID-19 seem especially susceptible, as do those with other health risk factors such as cancer, obesity and a history of blood clots.
Knowing this, health care providers have changed the way they treat COVID-19 patients to specifically address the risk of clotting. It’s taken quick, widespread collaboration. At the Wexner Medical Center, specialty practice pharmacists along with critical care medicine, cardiology, hematology, emergency medicine and internal medicine doctors developed guidelines on how to manage these patients, Dr. Blais says.
“We’ve done the amount of work that some people would take a year or two to put together in a matter of weeks,” she says.
Now, patients who are sick enough from COVID-19 to go to the hospital receive blood tests to gauge the activity of clotting in their blood vessels. Recent studies have demonstrated that patients with COVID-19 are prone to clotting, but patients in the ICU may also be at risk for bleeding.
"Health care providers must carefully weigh the risks and benefits of anticoagulation for each individual patient," Dr. Exline says.
Those whose clotting systems aren’t particularly active receive treatments to prevent clots such as compression socks, inflatable cushions for their calves or small injections of blood thinners. Those with more active clotting systems receive full doses of blood thinners if they’re not at a high bleeding risk.
“We’re having to be thoughtful about our approach with treatment, especially because there is limited data in COVID-19 patients,” said Tiffany Ortman, PharmD, a specialty practice pharmacist in outpatient care at the Ross Heart Hospital.
After patients leave the hospital, health care providers continue to monitor patients for clotting symptoms and lower their risk through medications. Some currently active research studies are attempting to understand how long patients should stay on anticoagulation medication as they recover from COVID-19.
While those with severe cases of COVID-19 appear to be more affected by blood clots, those who don’t come to the hospital could still be at risk.
They, as everyone, should monitor for signs of clots and possible stroke or heart attack:
Call 911 if you’re experiencing concerning symptoms.
Our experts' biggest recommendation for those with COVID-19 at home: Keep moving. Stay hydrated. When you are seated, try to keep your legs elevated.
Keep the blood, quite literally, flowing.
We have appointments available as early as today.
Schedule now